We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Olink Logo

Olink

Olink offers a high-multiplex technique to identify actionable biomarkers with a strong focus on the human plasma proteome. Their mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology.

Latest Olink Content

Olink
Webinar

Population-Level Multiomics for Precision Medicine

Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.
Two scientists in lab coats standing in front of sequencing machines in a lab.
Product News

New State-of-the-Art Genomic Services Facility Opening in the UK

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.
Mouse
Whitepaper

Detect Low Abundance Biomarkers in Murine Models

In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.
O link
Webinar

Advancing Biomarker Discovery in Ovarian Cancer With High-Throughput Proteomics

On-Demand
This webinar describes how a new platform for high-throughput proteomics was used to identify multiple proteins associated with ovarian cancer. A 22-protein model was derived that discriminates ovarian cancer cases from benign controls with high accuracy.
PEA Technology  content piece image
Product
Advertisement

PEA Technology

Proximity Extension Assay (PEA) technology is the unique technology behind our Olink® Explore platform and Olink® Target 96 and Target 48 panels.
Olink® Signature Q100 content piece image
Product
Advertisement

Olink® Signature Q100

Run Olink kits easy and convenient in your own lab with Olink® Signature Q100, a dedicated solution for qPCR readout of Olink panels. With seamless integration between panel analysis to data output, you can simplify your research process with Olink® Target, Olink® Flex and Olink® Focus protein biomarker panels.
Olink® Flex content piece image
Product
Advertisement

Olink® Flex

Olink® Flex is a customizable made-to-order product that enables the selection and combination of up to 21 human proteins into one biomarker panel. Mix and match from ~200 thoroughly pre-validated protein biomarkers.
Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas content piece image
Product
Advertisement

Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas

Mix and match up to 21 protein assays with 99% combinability. Each and every assay is transparently validated to the highest standards and you can be fully confident that whatever combination of assays you select will work together and deliver high quality data with excellent specificity, sensitivity, and dynamic range
Olink® Flex – Inflammation Research on Your Terms content piece image
Product
Advertisement

Olink® Flex – Inflammation Research on Your Terms

Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute quantification (pg/mL) and relative quantification (NPX). Pick and choose from over 200 inflammation-related human proteins with 99% combinability in a broad mix-and-match library.
Utilizing NGS for Proteomics - Olink® to Accelerate Drug Discovery and Optimize Clinical Trials Outcome content piece image
Webinar

Utilizing NGS for Proteomics - Olink® to Accelerate Drug Discovery and Optimize Clinical Trials Outcome

On-Demand
Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Karsten Strauss from Olink delivered his talk on how Olink are able to provide a platform of products and services that are deployed across major pharmaceutical companies.
Advertisement